| 发明名称 |
Immune Effector Cells Pre-Infected with Oncolytic Virus |
| 摘要 |
Compositions and methods are provided for the treatment of cancer. An immune effector cell population is pre-infected with an oncolytic virus. The combined therapeutic is safe and highly effective, producing an enhanced anti-tumor effect compared to either therapy alone. The methods of the invention thus provide for a synergistic effect based on the combined biotherapeutics. |
| 申请公布号 |
US2015320800(A1) |
申请公布日期 |
2015.11.12 |
| 申请号 |
US201514792424 |
申请日期 |
2015.07.06 |
| 申请人 |
The Board of Trustees of the Leland Stanford Junior University |
发明人 |
Contag Christopher H.;Thorne Stephen H. |
| 分类号 |
A61K35/17;C12N5/0783 |
主分类号 |
A61K35/17 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An isolated mammalian immune effector cell population, infected with an oncolytic virus. |
| 地址 |
Stanford CA US |
